Joint (NASDAQ:JYNT) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Joint (NASDAQ:JYNT) from a hold rating to a buy rating in a research report report published on Saturday.

A number of other brokerages have also issued reports on JYNT. Weiss Ratings lowered shares of Joint from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday. Zacks Research lowered shares of Joint from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $18.00.

Joint Trading Up 0.2%

Shares of JYNT stock opened at $8.69 on Friday. Joint has a 1 year low of $7.50 and a 1 year high of $13.47. The firm’s 50 day moving average is $8.71 and its 200-day moving average is $8.81. The firm has a market capitalization of $124.44 million, a price-to-earnings ratio of 37.78 and a beta of 1.11.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. Joint had a net margin of 5.72% and a return on equity of 6.58%. The company had revenue of $14.82 million for the quarter, compared to analyst estimates of $14.50 million. On average, equities research analysts forecast that Joint will post 0.31 earnings per share for the current fiscal year.

Insider Buying and Selling at Joint

In other Joint news, major shareholder Charles E. Jobson purchased 15,397 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was acquired at an average cost of $8.50 per share, with a total value of $130,874.50. Following the completion of the purchase, the insider directly owned 1,645,294 shares in the company, valued at approximately $13,984,999. This represents a 0.94% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have purchased 16,354 shares of company stock worth $139,139 over the last ninety days. Insiders own 30.20% of the company’s stock.

Institutional Investors Weigh In On Joint

A number of institutional investors and hedge funds have recently modified their holdings of the business. Skylands Capital LLC raised its stake in shares of Joint by 0.4% during the first quarter. Skylands Capital LLC now owns 893,195 shares of the company’s stock worth $7,905,000 after buying an additional 3,150 shares during the last quarter. JCP Investment Management LLC raised its stake in shares of Joint by 24.0% during the third quarter. JCP Investment Management LLC now owns 593,906 shares of the company’s stock worth $5,666,000 after buying an additional 115,062 shares during the last quarter. Topline Capital Management LLC raised its stake in shares of Joint by 18.7% during the second quarter. Topline Capital Management LLC now owns 449,204 shares of the company’s stock worth $5,184,000 after buying an additional 70,910 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Joint by 17.6% during the second quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock worth $3,986,000 after buying an additional 51,704 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Joint by 0.8% during the fourth quarter. State Street Corp now owns 292,123 shares of the company’s stock worth $2,547,000 after buying an additional 2,341 shares during the last quarter. 76.88% of the stock is owned by institutional investors.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.